Danish Lung Cancer Screening Trial (DLCST): Preliminary Results After Five Annual Screening Rounds With Low Dose CT
Zaigham Saghir(Gentofte Hospital), Jesper Holst Pedersen(Reykjavík Energy (Iceland)), Martin Døssing(Frederiksberg Hospital), Haseem Ashraf(University of Oslo), Klaus Richter Larsen(Bispebjerg Hospital), John Brodersen(University of Copenhagen), Niels Seersholm, Asger Dirksen, Jann Mortensen(Copenhagen University Hospital), Klaus F. Kofoed(University of Copenhagen), Philip Tønnesen(Gentofte Hospital), Paul Frost Clementsen(Gentofte Hospital), Birgit Guldhammer Skov(Gentofte Hospital), Hanne Helene Hansen(University of Copenhagen), Karen Bach(Gentofte Hospital), Hanne Thorsen(University of Copenhagen)
Cited by 4
Related Papers
Detection and characterization of lung cancer using cell-free DNA fragmentomes
|Nature Communications|2021|458
The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round
|Journal of Thoracic Oncology|2009|440
Overdiagnosis: what it is and what it isn’t
|BMJ Evidence-Based Medicine|2018|368
Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling
|American Journal of Respiratory and Critical Care Medicine|2015|343